Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D-Reference-Cited by-同舟云学术

Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D

Published:2017-10-19 Issue:3 Volume:86 Page:595-628
ISSN:0022-4367
Container-title:Journal of Risk and Insurance
language:en
Short-container-title:Journal Risk and Insurance

Author:

Kaestner Robert,Schiman Cuping,Alexander G. Caleb

Funder

National Institute of Aging, National Institutes of Health

Publisher

Wiley

Subject

Economics and Econometrics,Finance,Accounting

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jori.12229

Reference45 articles.

1. The Impact of Medicare Part D on Hospitalization Rates;Afendulis C. C.;Health Services Research,2011

2. Patient Cost‐ Sharing, Hospitalization Offsets, and the Design of Optimal Health Insurance for the Elderly;Chandra A.;American Economic Review,2010

3. Cohen R. A. andD. M.Makuc 2008 State Regional and National Estimates of Health Insurance for People Under 65 Years of Age: National Health Interview Survey 2004–2006 National Health Statistics Reports: No 1 National Center for Health Statistics Hyattsville MD.

4. Congressional Budget Office 2012 Offsetting Effects of Prescription Drug Use on Medicare's Spending for Medical Services. Available athttp://www.cbo.gov/sites/default/files/cbofiles/attachments/43741MedicalOffsets‐11‐29‐12.pdf(accessed May 7 2013).

5. The Effect of Medicare Part D on Pharmaceutical Prices and Utilization;Duggan M.;American Economic Review,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Human Cost of Collusion: Health Effects of a Mexican Insulin Cartel;Journal of the European Economic Association;2023-02-02

2. Ending Pay for PBM Performance: Consequences for Prescription Drug Prices, Utilization, and Government Spending;SSRN Electronic Journal;2023

3. Ending Pay for Pbm Performance: Consequences for Prescription Drug Prices, Utilization, and Government Spending;SSRN Electronic Journal;2023

4. Pharmaceutical policies: effects of regulating drug insurance schemes;Cochrane Database of Systematic Reviews;2022-05-03

5. Effects of utilization management on health outcomes: evidence from urinary tract infections and community-acquired pneumonia;Expert Review of Pharmacoeconomics & Outcomes Research;2022-04-27